Skip to main content
Login
Contact
Subscribe
Search form
Search
The Punxsutawney Spirit
Home
Forms
Delivery Concerns
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Local Guide
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Adverum Biotechnlgs
(NQ:
ADVM
)
9.770
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
5:28 PM EST, Nov 20, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
9.770
Bid (Size)
9.800 (15)
Ask (Size)
10.50 (10)
Prev. Close
9.770
Today's Range
9.770 - 9.770
52wk Range
2.810 - 16.38
Shares Outstanding
62,271,901
Dividend Yield
N/A
Performance
YTD
+186.51%
+186.51%
1 Month
+37.99%
+37.99%
3 Month
-17.55%
-17.55%
6 Month
+5.51%
+5.51%
1 Year
+169.89%
+169.89%
Top News
More News
Adverum Biotechnologies to Participate in Piper Jaffray’s 31st Annual Healthcare Conference
November 20, 2019
from
GlobeNewswire News Releases
Adverum Biotechnologies Shareholder Alert – Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of Investors of Adverum Biotechnologies, Inc. - ADVM
November 11, 2019
from
GlobeNewswire News Releases
More News
Read More
Adverum Biotechnologies Reports Recent Business Progress and Third Quarter 2019 Financial Results
November 07, 2019
from
GlobeNewswire News Releases
Adverum Biotechnologies to Host a Conference Call and Webcast to Report Third Quarter 2019 Financial Results and Provide Corporate Updates
October 31, 2019
from
GlobeNewswire News Releases
Adverum Biotechnologies Expands Leadership Team with the Appointment of Peter Soparkar as Chief Legal Officer
October 30, 2019
from
GlobeNewswire News Releases
Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress
October 23, 2019
from
GlobeNewswire News Releases
Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual
October 11, 2019
from
GlobeNewswire News Releases
First Week of ADVM June 2020 Options Trading
October 31, 2019
category
Stocks
from
Market News Video
Adverum Biotechnologies, Inc. (ADVM) Q3 2019 Earnings Call Transcript
November 09, 2019
category
Market News
,
ADVM
from
Motley Fool
Monday's ETF Movers: IBB, XOP
October 14, 2019
category
ETFs
from
ETF Channel
Mid-Day Market Update: Crude Oil Down 2.5%; 21Vianet Group Shares Jump
October 14, 2019
category
VNET
,
Markets
,
Market News
, and 15 more.
from
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
